C-suite managers for Swiss startups

Clinerion provides its proprietary Patient Network Explorer that radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. As of January 1, 2021, Boris Erdogan will take up his new role as CEO succeeding Ian Rentsch. Erdogan, currently Vice President, Site & Patient Networks, gained experience managing innovative medical informatics projects and implementing end-to-end healthcare IT enterprise information systems, both in the public and private sectors. He joined Clinerion in 2013 and has been the main driver of the continued rapid expansion of Clinerion’s global clinical network, currently with real-time, live data reach of more than 33 million patients in 17 countries in Europe, Asia and Latin America.

Advertima, the leading computer vision company, has welcomed Thomas Pollum, former Managing Director EMEA at Navori, as Head of Global Sales, and Carsten Berkenbrink, former Senior Digital Signage Expert at Toshiba Germany, as Senior Sales Director. They bring with them more than 20 years’ experience each to strengthen Advertima’s position as the leader in the retail and digital signage technology market.

Nouscom has appointed Richard Davis, as Chief Business Officer (CBO). Davis is an accomplished executive with more than 20 years' experience in the life sciences sector, focusing on developing and building strategic partnerships and growth strategies. Before joining Nouscom, he was Global Oncology Transactor at Johnson & Johnson Innovation. Davis held executive roles in both private and public European biotech companies and has been responsible for maximizing financial returns on direct healthcare investments in both private and public equities and venture capital funds at the Wellcome Trust. During this time, he was on the Board of Directors of several biotech companies and worked closely with management teams on strategy, financing and exits via M&A and public listings.

Lyfegen, a health-tech startup providing software to accelerate value-based healthcare contracting has added Frederico Braga to its management board. Brage is a proven technology executive with more than 20 years of experience. After leading large IT transformation teams for IBM before, he moved into the Life Sciences field. He spent the last ten years leading large IT teams at Novo Nordisk (NNIT), Medidata Solutions and building up the European business of HighPoint Solutions before IQVIA acquired it. His expertise will be relevant in growing Lyfegen’s value-based healthcare technology platform.

(Press release/RAN)